+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor Drug"

From
From
From
From
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 280 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
From
From
Hepatic Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatic Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Desmoid Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Tumor Drug market is a subset of the Oncology Drugs market, which focuses on the development and sale of drugs used to treat cancer. These drugs are used to target and destroy cancer cells, reduce the size of tumors, and reduce the spread of cancer. Tumor drugs are typically divided into two categories: cytotoxic drugs, which kill cancer cells, and targeted therapies, which target specific molecules involved in cancer growth. These drugs are often used in combination with other treatments, such as radiation and surgery, to maximize the effectiveness of treatment. The Tumor Drug market is highly competitive, with many companies developing and selling drugs to treat cancer. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies, such as AstraZeneca, Eli Lilly, and Amgen, are also active in the market. Show Less Read more